• VISHAL YADAV Department of Pharmaceutics, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai 600117, India
  • S. SATHESH KUMAR Department of Pharmaceutics, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai 600117, India


Objective: Objective of the study was to develop tamoxifen citrate immediate release pellets by hot-melt extrusion (HME) and to study the effect of various formulation and process variables.

Methods: Pellets were prepared by HME technique. Effect of various parameters such as the concentration of ethylcellulose, PEG 6000, croscarmellose sodium, and spheronization speed were studied by using Central Composite Design. Pellets were evaluated for theoretical yield (%), mean pellet size (mm), sphericity (pellips), friability (%), porosity (%), mechanical crushing force (n), and dissolution efficiency. Optimized formulation was studied for compatibility study using IR, DSC, and XRD, SEM, In vitro drug release. In vitro Cell Cytotoxicity and Viability Assay were carried out using MCF-7 (human breast cancer cells) by MTT assay.

Results: Results showed that a variable such as the amount of Methyl Cellulose, PEG 6000 and Spheronization speed showed positive correlation and amount of Croscarmellose sodium showed a negative correlation with dependent variables. Optimized formulation showed Korsmeyer Peppas model as a mechanism of drug release. Value of n was found to be in between 0.77+0.04, which reveals that, release mechanism of the drug as non-Fickian transport (0.45<n<0.89). MTT results of MCF-7 cells showed that optimized immediate release pellets have maximum cytotoxicity at 80 µg/ml.

Conclusion: Study concluded that HME method and materials i.e. PEG 6000 and methylcellulose can effectively use to get immediate release of tamoxifen citrate so as to increase dissolution rate and cytotoxic effect.

Keywords: Tamoxifen citrate, Pellets, Hot-melt extrusion, Immediate release, Central composite design


1. Monteagudo E, Gandola Y, Gonzalez L, Bregni C, Carlucci AM. Development, characterization, and in vitro evaluation of tamoxifen microemulsions. J Drug Delivery 2012:1-11.
2. Wu CB, McGinity JW. Influence of methylparaben as a solid-state plasticizer on the physicochemical properties of Eudragit (R) RS PO hot-melt extrudates. Eur J Pharm Biopharm 2003;56:95–100.
3. Reddy LH, Vivek K, Bakshi N, Murthy RSR. Tamoxifen citrate loaded solid lipid nanoparticles (SLN™): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation. J Pharm Dev Tech 2006;11:167-77.
4. Borgna JL, Rochefort H. High-affinity binding to the estrogen receptor of [3H] 4-hydroxy tamoxifen, an active antiestrogen metabolite. Mol Cell Endocrinol 1980;20:71-85.
5. Shin SC, Choi JS, Li X. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats. Int J Pharm 2006;313:144-9.
6. Gao S, Singh J. In vitro percutaneous absorption enhancement of lipophilic drug tamoxifen by terpenes. J Controlled Release 1998;5:193-9.
7. Koo OMYK, Heng PWS. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization. Chem Pharm Bull 2001;49:1383-7.
8. Howard MA, Neau SH, Marvin JS. PEO and MPEG in high drug load extruded and spheronized beads that are devoid of MCC. Int J Pharm 2006;307:66-76.
9. Rehana BA, Ganesh NS, Vineeth C. A study on different pellet formation techniques and its evaluation parameters-a review. Int J Curr Pharm Res 2019;11:7-13.
10. Podczeck F, Rahman SR, Newton JM. Evaluation of a standardized procedure to assess the shape of pellets using image analysis. Int J Pharm 1999;192:123–8.
11. Almeida Prieto S, Blanco Mendez J, Otero Espinar FJ. Microscopic image analysis techniques for the morophologicalcharterization of pharmaceutical particles: influence of the software and the factor algorithms used in the shape factor estimation. Eur J Pham Biopharm 2007;67:766-76.
12. Chopra R, Newton JM, Alderborn G, Podczeck F. Preparation of pellets of different shape and their characterization. Pharm Develop Technol 2001;6:495-503.
13. Steckel H, Mindermann Nogly F. Production of chitosan pellets by extrusion/spheronization. Eur J Pharm Biopharm 2004;57:105-14.
14. Tongwen X, Binglin H. Mechanism of sustained drug release in diffusion controlled polymer matrix application of percolation theory. Int J Pharma 1998;170:139-49.
15. Sousa A, Podczeck F, Newton JM. Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization. Int J Pharm 2002;232:91-106.
16. Newton JM, Pinto MR, Podczeck F. The preparation of pellets containing a surfactant or a mixture of mono-and di-glycerides by extrusion/spheronization. Eur J Pharm Sci 2007;30:333-42.
17. Ahuja N, Katare OP, Singh B. Studies on dissolution enhancement and mathematical modeling of drug release of poorly water-soluble drug using water-soluble carriers. Eur J Pharm Biopharm 2007;65:26-38.
18. Friedrich H, Nada A, Bodmeier R. Solid state and dissolution rate characterization of Co-ground mixtures of nifedipine and hydrophilic carriers. Drug Dev Ind Pharm 2005;31:719-28.
19. Sonaglio D, Beringhs AO, Porfírio A, Bataille B. On the factors influencing the extrusion strain, particle size and dissolution behavior of multiparticulate systems obtained by extrusion/spheronization. Powder Technol 2012;230:54–62.
20. Emara LH, Abdelfattah FM, Taha NF, El-Ashmawy AA, Mursi NM. In vitro evaluation of ibuprofen hot-melt extruded pellets employing different designs of the flow through cell. Int J Pharm Pharm Sci 2014;6:192-7.
21. Chamsai B, Sriamornsak P. Novel disintegrating microcrystalline cellulose pellets with improved drug dissolution performance. Powder Technol 2013;233:278–85.
22. Patadia J, Tripathi R, Joshi A. Melt-in-mouth multiparticulate system for the treatment of ADHD: a convenient platform for pediatric use. AAPS PharmSciTech 2016;17:878-90.
23. Kim MS, Jin SJ, Kim JS, Park HJ, Song H, Neubert RHH, et al. Preparation, characterization, and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) technique. Eur J Pharm Biopharm 2008;69:454-65.
24. Maghraby GM, Alomrani AH. Synergistic enhancement of itraconazole dissolution by ternary system formulation with pluronic F68 and hydroxypropylmethylcellulose. Sci Pharm 2009;77:401–17.
25. Goddeeris C, Van den Mooter G. Free flowing solid dispersions of the anti-HIV UC 781 with poloxamer 407 and a maximum amount of TGPS 1000: investigating the relationship between physicochemical characteristics and dissolution behavior. Eur J Pharm Sci 2008;35:104-13.
26. Waseda Y, Matsubara E, Shinoda K. X-Ray diffraction crystallography introduction, examples and solved problems. Springer, Germany; 2011.
27. Pradhan DK, Chaudhary RNP, Samantharay BK, Karan NK, Katiyar RS. Effect of plasticizer on structural and electrical properties of polymer nanocomposite electrolytes. Int J Electrochem Sci 2007;2:861-71.
28. Sharma S, Kumar V. In vitro cytotoxicity effect on mcf-7 cell line of co-encapsulated artesunate and curcumin liposome. Int J Pharm Pharm Sci 2017;9:123-8.
211 Views | 257 Downloads
How to Cite
Original Article(s)